HomeBVX • LON
Follow
Bivictrix Therapeutics PLC
Previous close
GBX 11.75
Year range
GBX 9.00 - GBX 16.00
Market cap
9.70M GBP
Avg Volume
4.17K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 695.00K | -10.32% |
Net income | -585.50K | 12.61% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -657.00K | 13.95% |
Effective tax rate | 15.76% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.90M | -58.14% |
Total assets | 3.46M | -39.89% |
Total liabilities | 625.00K | -10.71% |
Total equity | 2.83M | — |
Shares outstanding | 66.12M | — |
Price to book | 2.94 | — |
Return on assets | -50.26% | — |
Return on capital | -53.58% | — |
Cash Flow
Net change in cash
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -585.50K | 12.61% |
Cash from operations | -611.50K | 7.42% |
Cash from investing | -80.00K | 17.53% |
Cash from financing | — | — |
Net change in cash | -691.50K | 8.71% |
Free cash flow | -453.38K | 15.71% |
About
Founded
2016
Website
Employees
17